| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |